Menu
Back to Journals » OncoTargets and Therapy » Volume 11
RETRACTED ARTICLE: Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145
Authors Wu J, Du M, Zhang Q, Zhang W, Fan Y, Yin L, Fei Q, Jiang X, Chen W, Zhu H, Yan P, He X , Bian X
Received 2 August 2018
Accepted for publication 28 September 2018
Published 25 October 2018 Volume 2018:11 Pages 7483—7492
DOI https://doi.org/10.2147/OTT.S182290
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Carlos E Vigil
This paper has been retracted.
Wu J, Du M, Zhang Q, et al. Onco Targets Ther. 2018;11:7483–7492.
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.
Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images from Figures 2 and 4. Specifically,
- The images for Figure 2E, CNE-2, Migration, si-UCA1 and Invasion, siRNA-NC, have been duplicated with the images for Figure 4C, CNE-2, Migration, Inhibitor NC+si-UCA1 and Inhibitor NC+siRNA-NC, respectively.
- The images for Figure 4C, 5–8 F, Migration and Invasion, Inhibitor NC+si-UCA1, have been duplicated.
When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As the findings could not be verified the Editor and Publisher made the decision to retract the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.